Replies to post #135677 on Biotech Values

[dewophile]

wow
that is one misleading PR
thanks!

[ghmm]

Sure ask and end all the speculation :).

The price movement seems even more unjustified.

[mcbio]

BLRX/BL-8020

I've asked and just got an answer: it is indeed an oral NS3/4A protease inhibitor.

Wow, thanks for confirming genisi. I don't know if I want to go as far as saying this renders the BLRX PR misleading (due to claims about a novel target), but it's the kind of PR normally issued by less credible small-cap biotech firms IMHO. I've been pretty bullish on the stock for awhile, given the diverse pipeline and small market cap (though unfortunately never took a position), and even after the pop the market cap seems pretty cheap to me in the grand scheme of things, but this kind of PR now has me second-guessing management credibility. Maybe that's too harsh but that's kind of my gut feel.

[rkrw]

BLRX. Here's some more detail from Bioworld.

http://www.bioworld.com/content/biolinerx-expands-pipeline-pursues-oral-hcv-treatment